Blood Plasma Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Blood Plasma Market to 2027 - Global Analysis and Forecasts By Components(Albumin, Coagulation Factors, Immunoglobin, Hyperimmune and Other Plasma Fractionation Products); Application(Oncology, Rheumatology, Neurology, Transplant, Immunology, Pulmonology and Hematology); End User(Research laboratories, hospitals and clinics and academic institutions.)

Report Code: TIPRE00003721 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Blood Plasma is the liquid portion of the blood which is a versatile component comprising 55% of blood. Plasma is a medium for the exchange of nutrients, proteins and hormones that regulates the blood pressure and body temperature.

MARKET DYNAMICS
The Blood Plasma market is anticipated to grow in the forecast period owing to driving factors such as increasing requirement for the blood plasma, increase in health related problems due to changing lifestyle, growing penetration of the products that are derived from plasma, increasing healthcare expenditure, increasing awareness about the disease, rising educational programs and presence of organized network of donor centers. Nevertheless, implementation of stringent regulations in the plasma collection, high cost involvement and misdiagnosis of the diseases may hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Blood Plasma Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Blood Plasma market with detailed market segmentation by components, application, end user and geography. The global Blood Plasma market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Blood Plasma market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Blood Plasma market is segmented on the basis of Components, Application and End-User. On the basis of components the market is segmented as Albumin, Coagulation Factors, Immunoglobin, Hyperimmune and Other Plasma Fractionation Products. On the basis of application the market is segmented as Oncology, Rheumatology, Neurology, Transplant, Immunology, Pulmonology and Hematology. On the basis of end-user the market is segmented as Research laboratories, hospitals and clinics and academic institutions.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Blood Plasma market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Blood Plasma market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Blood Plasma market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Blood Plasma market in these regions.

MARKET PLAYERS
The reports cover key developments in the Blood Plasma Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Blood Plasma Market are anticipated to lucrative growth opportunities in the future with the rising demand for Blood Plasma in the global market. Below mentioned is the list of few companies engaged in the Blood Plasma market.

The report also includes the profiles of key Blood Plasma market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • CSL
  • Grifols
  • Shire
  • Octapharma
  • Kedrion
  • LFB
  • Biotest
  • Sanquin
  • China Biologic Products
  • Bio Products Laboratory
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Plasma Market - By Componets
1.3.2 Blood Plasma Market - By Application
1.3.3 Blood Plasma Market - By End User
1.3.4 Blood Plasma Market - By Region
1.3.4.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. BLOOD PLASMA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BLOOD PLASMA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BLOOD PLASMA MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD PLASMA - GLOBAL MARKET OVERVIEW
6.2. BLOOD PLASMA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. BLOOD PLASMA MARKET - REVENUE AND FORECASTS TO 2027 - COMPONETS
7.1. OVERVIEW
7.2. COMPONETS MARKET FORECASTS AND ANALYSIS
7.3. ALBUMIN
7.3.1. Overview
7.3.2. Albumin Market Forecast and Analysis
7.4. COAGULATION FACTORS
7.4.1. Overview
7.4.2. Coagulation factors Market Forecast and Analysis
7.5. IMMUNOGLOBIN
7.5.1. Overview
7.5.2. Immunoglobin Market Forecast and Analysis
7.6. HYPERIMMUNE
7.6.1. Overview
7.6.2. Hyperimmune Market Forecast and Analysis
7.7. AND OTHER PLASMA FRACTIONATION PRODUCTS
7.7.1. Overview
7.7.2. and Other Plasma Fractionation Products Market Forecast and Analysis

8. BLOOD PLASMA MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. RHEUMATOLOGY
8.4.1. Overview
8.4.2. Rheumatology Market Forecast and Analysis
8.5. NEUROLOGY
8.5.1. Overview
8.5.2. Neurology Market Forecast and Analysis
8.6. TRANSPLANT
8.6.1. Overview
8.6.2. Transplant Market Forecast and Analysis
8.7. IMMUNOLOGY
8.7.1. Overview
8.7.2. Immunology Market Forecast and Analysis
8.8. PULMONOLOGY AND HEMATOLOGY
8.8.1. Overview
8.8.2. Pulmonology and Hematology Market Forecast and Analysis

9. BLOOD PLASMA MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. RESEARCH LABORATORIES
9.3.1. Overview
9.3.2. Research laboratories Market Forecast and Analysis
9.4. HOSPITALS AND CLINICS
9.4.1. Overview
9.4.2. Hospitals and Clinics Market Forecast and Analysis
9.5. AND ACADEMIC INSTITUTIONS.
9.5.1. Overview
9.5.2. and Academic Institutions. Market Forecast and Analysis

10. BLOOD PLASMA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Blood Plasma Market Overview
10.1.2 North America Blood Plasma Market Forecasts and Analysis
10.1.3 North America Blood Plasma Market Forecasts and Analysis - By Componets
10.1.4 North America Blood Plasma Market Forecasts and Analysis - By Application
10.1.5 North America Blood Plasma Market Forecasts and Analysis - By End User
10.1.6 North America Blood Plasma Market Forecasts and Analysis - By Countries
10.1.6.1 United States Blood Plasma Market
10.1.6.1.1 United States Blood Plasma Market by Componets
10.1.6.1.2 United States Blood Plasma Market by Application
10.1.6.1.3 United States Blood Plasma Market by End User
10.1.6.2 Canada Blood Plasma Market
10.1.6.2.1 Canada Blood Plasma Market by Componets
10.1.6.2.2 Canada Blood Plasma Market by Application
10.1.6.2.3 Canada Blood Plasma Market by End User
10.1.6.3 Mexico Blood Plasma Market
10.1.6.3.1 Mexico Blood Plasma Market by Componets
10.1.6.3.2 Mexico Blood Plasma Market by Application
10.1.6.3.3 Mexico Blood Plasma Market by End User
10.1.6.4 US Blood Plasma Market
10.1.6.4.1 US Blood Plasma Market by Componets
10.1.6.4.2 US Blood Plasma Market by Application
10.1.6.4.3 US Blood Plasma Market by End User
10.2. EUROPE
10.2.1 Europe Blood Plasma Market Overview
10.2.2 Europe Blood Plasma Market Forecasts and Analysis
10.2.3 Europe Blood Plasma Market Forecasts and Analysis - By Componets
10.2.4 Europe Blood Plasma Market Forecasts and Analysis - By Application
10.2.5 Europe Blood Plasma Market Forecasts and Analysis - By End User
10.2.6 Europe Blood Plasma Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Blood Plasma Market
10.2.6.1.1 Germany Blood Plasma Market by Componets
10.2.6.1.2 Germany Blood Plasma Market by Application
10.2.6.1.3 Germany Blood Plasma Market by End User
10.2.6.2 France Blood Plasma Market
10.2.6.2.1 France Blood Plasma Market by Componets
10.2.6.2.2 France Blood Plasma Market by Application
10.2.6.2.3 France Blood Plasma Market by End User
10.2.6.3 Italy Blood Plasma Market
10.2.6.3.1 Italy Blood Plasma Market by Componets
10.2.6.3.2 Italy Blood Plasma Market by Application
10.2.6.3.3 Italy Blood Plasma Market by End User
10.2.6.4 Spain Blood Plasma Market
10.2.6.4.1 Spain Blood Plasma Market by Componets
10.2.6.4.2 Spain Blood Plasma Market by Application
10.2.6.4.3 Spain Blood Plasma Market by End User
10.2.6.5 United Kingdom Blood Plasma Market
10.2.6.5.1 United Kingdom Blood Plasma Market by Componets
10.2.6.5.2 United Kingdom Blood Plasma Market by Application
10.2.6.5.3 United Kingdom Blood Plasma Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Blood Plasma Market Overview
10.3.2 Asia-Pacific Blood Plasma Market Forecasts and Analysis
10.3.3 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By Componets
10.3.4 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Blood Plasma Market
10.3.6.1.1 Australia Blood Plasma Market by Componets
10.3.6.1.2 Australia Blood Plasma Market by Application
10.3.6.1.3 Australia Blood Plasma Market by End User
10.3.6.2 China Blood Plasma Market
10.3.6.2.1 China Blood Plasma Market by Componets
10.3.6.2.2 China Blood Plasma Market by Application
10.3.6.2.3 China Blood Plasma Market by End User
10.3.6.3 India Blood Plasma Market
10.3.6.3.1 India Blood Plasma Market by Componets
10.3.6.3.2 India Blood Plasma Market by Application
10.3.6.3.3 India Blood Plasma Market by End User
10.3.6.4 Japan Blood Plasma Market
10.3.6.4.1 Japan Blood Plasma Market by Componets
10.3.6.4.2 Japan Blood Plasma Market by Application
10.3.6.4.3 Japan Blood Plasma Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Blood Plasma Market Overview
10.4.2 Middle East and Africa Blood Plasma Market Forecasts and Analysis
10.4.3 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By Componets
10.4.4 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Blood Plasma Market
10.4.6.1.1 South Africa Blood Plasma Market by Componets
10.4.6.1.2 South Africa Blood Plasma Market by Application
10.4.6.1.3 South Africa Blood Plasma Market by End User
10.4.6.2 Saudi Arabia Blood Plasma Market
10.4.6.2.1 Saudi Arabia Blood Plasma Market by Componets
10.4.6.2.2 Saudi Arabia Blood Plasma Market by Application
10.4.6.2.3 Saudi Arabia Blood Plasma Market by End User
10.4.6.3 U.A.E Blood Plasma Market
10.4.6.3.1 U.A.E Blood Plasma Market by Componets
10.4.6.3.2 U.A.E Blood Plasma Market by Application
10.4.6.3.3 U.A.E Blood Plasma Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Blood Plasma Market Overview
10.5.2 South and Central America Blood Plasma Market Forecasts and Analysis
10.5.3 South and Central America Blood Plasma Market Forecasts and Analysis - By Componets
10.5.4 South and Central America Blood Plasma Market Forecasts and Analysis - By Application
10.5.5 South and Central America Blood Plasma Market Forecasts and Analysis - By End User
10.5.6 South and Central America Blood Plasma Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Blood Plasma Market
10.5.6.1.1 Brazil Blood Plasma Market by Componets
10.5.6.1.2 Brazil Blood Plasma Market by Application
10.5.6.1.3 Brazil Blood Plasma Market by End User
10.5.6.2 Argentina Blood Plasma Market
10.5.6.2.1 Argentina Blood Plasma Market by Componets
10.5.6.2.2 Argentina Blood Plasma Market by Application
10.5.6.2.3 Argentina Blood Plasma Market by End User
10.5.6.3 Chile Blood Plasma Market
10.5.6.3.1 Chile Blood Plasma Market by Componets
10.5.6.3.2 Chile Blood Plasma Market by Application
10.5.6.3.3 Chile Blood Plasma Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BLOOD PLASMA MARKET, KEY COMPANY PROFILES
12.1. CSL
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GRIFOLS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SHIRE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. OCTAPHARMA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. KEDRION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LFB
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIOTEST AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANQUIN
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIO PRODUCTS LABORATORY LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. CSL
2. Grifols
3. Shire
4. Octapharma
5. Kedrion
6. LFB
7. Biotest
8. Sanquin
9. China Biologic Products
10. Bio Products Laboratory